After World-Leading COVID-19 Vaccine Roll-Out, UK Looks To Next Phase
But Under Pressure To Help Poorer Nations
Executive Summary
The UK’s purchase of 60 million extra Pfizer/BioNTech doses, plus bets on Novavax and Valneva and others gives it a buffer against new variants – so when will it pledge to donate to more needy nations?